Literature DB >> 17554716

Fluoroquinolones should not be the first-line antibiotics to treat community-acquired pneumonia in areas of tuberculosis endemicity.

Akashdeep Singh.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17554716     DOI： 10.1086/518702

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  3 in total

1.  Resistance profile of strains of Mycobacterium fortuitum isolated from clinical specimens.

Authors:  Debora Ribeiro de Souza Santos; Maria Cristina Silva Lourenço; Fábrice Santana Coelho; Fernanda Carvalho Queiroz Mello; Rafael Silva Duarte
Journal:  J Bras Pneumol       Date:  2016 Jul-Aug       Impact factor: 2.624

Review 2.  Does empirical treatment of community-acquired pneumonia with fluoroquinolones delay tuberculosis treatment and result in fluoroquinolone resistance in Mycobacterium tuberculosis? Controversies and solutions.

Authors:  Gwan-Han Shen; Thomas Chang-Yao Tsao; Shang-Jyh Kao; Jen-Jyh Lee; Yen-Hsu Chen; Wei-Chung Hsieh; Gwo-Jong Hsu; Yen-Tao Hsu; Ching-Tai Huang; Yeu-Jun Lau; Shih-Ming Tsao; Po-Ren Hsueh
Journal:  Int J Antimicrob Agents       Date:  2012-01-28       Impact factor: 5.283

Review 3.  Benzotriazole: An overview on its versatile biological behavior.

Authors:  I Briguglio; S Piras; P Corona; E Gavini; M Nieddu; G Boatto; A Carta
Journal:  Eur J Med Chem       Date:  2014-09-30       Impact factor: 6.514
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.